Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Name: Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway
Published: 2025
License: Public Domain

Regina Elena Cancer Institute · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

liquid-biopsy lung-cancer ngs non-small-cell-lung-cancer nsclc

advanced non-small cell lung cancer (nsclc), lung cancer, liquid biopsy, plasma-first approach, non-small cell lung cancer, nsclc, ctdna, ctrna, ngs, molecular profiling, tumor fraction, actionable genomic alterations

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 868680
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.